Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.
about
Neuroinvasion and Inflammation in Viral Central Nervous System InfectionsHIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentIntercellular Adhesion Molecular-5 as Marker in HIV Associated Neurocognitive Disorder.Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesisHIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.Interactions between ageing and NeuroAIDS.Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes.The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment.Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disordersPlasma cytokine levels are related to brain volumes in HIV-infected individuals.Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ARTChemokine CCL2 enhances NMDA receptor-mediated excitatory postsynaptic current in rat hippocampal slices-a potential mechanism for HIV-1-associated neuropathy?Identification and molecular characterization of SIV Vpr R50G mutation associated with long term survival in SIV-infected morphine dependent and control macaquesA concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons.Cognitive consequences of a sustained monocyte type 1 IFN response in HIV-1 infectionHIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.The Role of Shed PrPc in the Neuropathogenesis of HIV Infection.Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive DisordersChildhood maltreatment and HIV-associated neurocognitive disorders share similar pathophysiology: a potential sensitisation mechanism?Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.HIV-associated synaptic degeneration.Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.Neurosyphilis Increases Human Immunodeficiency Virus (HIV)-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals With Syphilis.Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity.Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection.Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSFStatin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.Buprenorphine decreases the CCL2-mediated chemotactic response of monocytesHIV-infected cannabis users have lower circulating CD16+ monocytes and IP-10 levels compared to non-using HIV patients.The role of catecholamines in HIV neuropathogenesis.
P2860
Q26745615-BB22FAB1-92AC-4BB6-A03C-5487B524CDFCQ26766448-3147FA4E-F884-4283-955F-F146F6A03A01Q33714228-4C773F18-4549-4BA3-9795-A3EC9282DB1EQ34902401-54DCBD08-8179-4ADF-8C38-094D6F222203Q34922069-ACF6EF35-C093-4336-8A97-AE5C03F2CA64Q34977613-2664E9F3-CB87-43BE-9498-F44A1DB13509Q34998247-5354DA5E-A847-43E4-816C-21D2E035EEC2Q35187881-B24D316D-1536-4EE4-B6BB-1578DFA38255Q35236882-3DFC2BBC-C7FF-4E8A-B847-5084E153ABC2Q35572270-22E00AFF-09A1-469A-935C-C08BDE77D945Q36316590-EFC63C3F-4987-4EA6-8929-22F57D8356DCQ37313212-6FFB42DC-EA84-43E5-B24D-CF344E60E586Q37352648-16BE4664-B6EC-42BA-9008-722B96BE88B5Q37416972-135C93EB-B7DC-43A3-AFC8-74472F98AB21Q37520967-35719146-2439-4B51-ACC3-908B8F52EA7EQ38214994-19358E0C-BA17-4F25-B461-47E8CAB8AA36Q38725384-890ADCB8-3716-4462-9132-96902DB94F20Q38769928-1155F277-83B5-4937-AE63-11EF4F30DF0AQ38948215-3910C008-D641-4703-A34E-A11A25236441Q39417239-FE777090-773E-4A2B-945E-A91A0106C380Q39967268-30E2EA65-40A0-44CE-AF33-5C03EB73E779Q40066321-29FA3DD8-762D-4B3A-B133-DAC3150DF487Q40175740-D41D51CA-576B-4DF8-8584-073A1C287B02Q40194358-076AF274-59EF-40F6-AF71-FEBEBA3F80EAQ40296944-A44C8A65-2BEF-4635-989B-A845B8E23858Q40437527-30A7C264-FA1C-4F32-8FDC-CDFE6CB8EA53Q40455681-BE3C9460-057E-4DFF-A635-DB5E89C1826AQ40618194-0D84FFC4-74CA-4614-A41B-2A7A3515D6FEQ40692788-8EF3A4C4-6C76-4295-96BC-4A14539DD7F8Q40738275-F1DBD71F-8928-48EF-B9B6-E9A3972929C3Q41463495-84109F8F-CBF5-4642-84E2-EDF5C1A901C3Q47342684-CAF8B98F-F392-406A-BB69-7056C3516F33Q53828206-2398E6A7-56A9-49F9-88B7-A4B638A37D54
P2860
Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cytokines in CSF correlate wit ...... n the post-HAART era in China.
@ast
Cytokines in CSF correlate wit ...... n the post-HAART era in China.
@en
type
label
Cytokines in CSF correlate wit ...... n the post-HAART era in China.
@ast
Cytokines in CSF correlate wit ...... n the post-HAART era in China.
@en
prefLabel
Cytokines in CSF correlate wit ...... n the post-HAART era in China.
@ast
Cytokines in CSF correlate wit ...... n the post-HAART era in China.
@en
P2093
P2860
P1476
Cytokines in CSF correlate wit ...... in the post-HAART era in China
@en
P2093
Jiming Yin
Lifeng Liu
Luxin Qiao
P2860
P2888
P304
P356
10.1007/S13365-013-0150-5
P50
P577
2013-02-07T00:00:00Z